0 results available. Select is focused ,type to refine list, press Down to open the menu,
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...
The following section summarizes insights on Inozyme Pharma Inc's Long Term Growth % Forecast Revision Date:
No data available
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Long Term Growth % Forecast Revision Date in the growth category include:
The date/time at which the current consensus estimate of forecasted long term growth was last updated.
No data available